Clinical Knowledge Library
High-yield clinical pathways and reasoning for SMLE preparation.
26 protocols available
Acute Otitis Media (AOM) in Pediatrics: Diagnosis and Management
Acute Otitis Media (AOM) is characterized by acute onset of symptoms (fever, ear pain) and signs of middle ear inflammation, such as a bulging tympanic membrane. The first-line antibiotic therapy for AOM is Amoxicillin, given at a high dose (80-90 mg/kg/day). Amoxicillin is effective against the most common bacterial pathogen, Streptococcus pneumoniae. If the patient has been treated with amoxicillin in the past 30 days, or has concurrent purulent conjunctivitis, Amoxicillin-clavulanate is preferred to cover beta-lactamase-producing organisms like H. influenzae.
AIDS
AIDS (Acquired Immunodeficiency Syndrome) is the final, most severe stage of HIV infection, characterized by a profoundly compromised immune system that makes individuals highly susceptible to opportunistic infections and certain cancers. It is diagnosed when the CD4+ T-cell count drops below 200 cells/mm³ or when specific AIDS-defining opportunistic illnesses develop. The cornerstone of AIDS treatment is highly active antiretroviral therapy (HAART), a combination of drugs that suppress HIV replication, preserve immune function, and prevent further progression. HAART significantly reduces viral load, increases CD4+ T-cell counts, and improves overall health. Treatment also includes prophylactic antibiotics to prevent opportunistic infections and specific therapies for any active infections or cancers. Symptoms of AIDS are primarily due to the opportunistic infections and cancers that take advantage of the severely weakened immune system. Common manifestations include persistent fever, chronic diarrhea, significant unintentional weight loss, night sweats, fatigue, swollen lymph nodes, and recurrent severe infections like Pneumocystis pneumonia, Kaposi's sarcoma, and toxoplasmosis. Neurological complications such as AIDS dementia complex can also occur.
Bradycardia
Bradycardia is a medical condition characterized by a slower than normal heart rate, typically defined as fewer than 60 beats per minute (bpm) in adults. While sometimes physiological and benign, it can also indicate underlying cardiovascular or systemic issues that impair the heart's ability to effectively pump blood. Treatment for bradycardia depends on its underlying cause, severity, and the presence of symptoms. Asymptomatic bradycardia, especially in athletes, often requires no intervention. Symptomatic bradycardia may necessitate discontinuing or adjusting causative medications, treating underlying conditions, or in severe cases, implanting a permanent pacemaker to regulate heart rhythm. Acute, unstable bradycardia may require intravenous atropine or temporary pacing. Clinical manifestations range from asymptomatic presentation to severe symptoms depending on the degree of bradycardia and the patient's cardiovascular reserve. Common symptoms include fatigue, dizziness, lightheadedness, syncope (fainting), shortness of breath, and chest pain. In critical cases, it can lead to confusion, hypotension, and signs of organ hypoperfusion.
Chronic Hepatitis C Virus infection
Chronic Hepatitis C Virus (HCV) infection is a persistent inflammatory condition of the liver caused by the hepatitis C virus, defined by the presence of detectable HCV RNA for at least six months. This long-term infection can progressively lead to significant liver damage, including fibrosis, cirrhosis, and hepatocellular carcinoma. Current treatment primarily involves direct-acting antiviral (DAA) medications, which are highly effective oral regimens targeting specific viral proteins to inhibit HCV replication. These therapies typically achieve a sustained virologic response (SVR) in over 95% of patients, effectively curing the infection. Treatment duration usually ranges from 8 to 12 weeks, depending on the specific regimen and patient factors. Chronic HCV infection is often asymptomatic for many years, leading to a silent progression of liver disease. When symptoms do appear, they are often non-specific, such as fatigue, malaise, nausea, and right upper quadrant discomfort. As the disease advances to cirrhosis, signs of liver decompensation may emerge, including jaundice, ascites, peripheral edema, spider angiomata, and hepatic encephalopathy.
Chronic hypertension
Chronic hypertension is a persistent and sustained elevation of blood pressure, typically defined as a systolic blood pressure greater than or equal to 130 mmHg or a diastolic blood pressure greater than or equal to 80 mmHg on multiple occasions. It is a major modifiable risk factor for various cardiovascular diseases, stroke, and kidney disease. Treatment for chronic hypertension involves a multi-faceted approach, starting with lifestyle modifications such as dietary changes (e.g., DASH diet), regular physical activity, weight loss, and reduced sodium and alcohol intake. Pharmacological therapy is often necessary and may include various classes of antihypertensive medications like diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and calcium channel blockers, frequently used in combination to achieve target blood pressure. Chronic hypertension is often referred to as 'the silent killer' because it is frequently asymptomatic for many years, even at high levels. When symptoms do occur, they are typically non-specific and may include headaches, dizziness, nosebleeds, or shortness of breath, usually manifesting in severe or long-standing cases or during a hypertensive crisis. Most diagnoses are made during routine medical screenings.
Cirrhosis
Cirrhosis is a late-stage liver disease characterized by the irreversible replacement of healthy liver tissue with extensive scar tissue (fibrosis) and regenerative nodules, leading to impaired liver function and progressive liver failure. This scarring disrupts the liver's normal structure and blood flow, severely compromising its ability to perform vital functions. Treatment for cirrhosis primarily focuses on addressing the underlying cause to prevent further liver damage and managing complications. This involves abstaining from alcohol, antiviral therapy for hepatitis, immunosuppressants for autoimmune conditions, diuretics for fluid retention (ascites/edema), and lactulose or rifaximin for hepatic encephalopathy. Liver transplantation is the definitive treatment for end-stage decompensated cirrhosis. Early stages of cirrhosis are often asymptomatic. As the disease progresses, common symptoms include fatigue, weakness, unintentional weight loss, nausea, and anorexia. Signs of decompensated cirrhosis may manifest as jaundice, ascites, peripheral edema, hepatic encephalopathy (confusion, lethargy), spider angiomas, palmar erythema, and easy bruising or bleeding.
COPD & Smoking Cessation Counseling: Ethical and Clinical Guidelines
When a patient consistently refuses recommended lifestyle changes such as smoking cessation, the most appropriate approach is to respect their autonomy while maintaining a supportive, non-judgmental stance. This ensures the therapeutic relationship is preserved and leaves the door open for future interventions when the patient is ready to reconsider. Physicians have a professional duty to provide care, and withdrawing care as a punitive measure for a patient's lifestyle choices is against medical ethics. Coercion or breaching confidentiality without explicit consent or imminent harm is highly unethical.
Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease (GERD) is a chronic digestive condition characterized by the backward flow of stomach acid or bile into the esophagus, causing irritation and inflammation. This reflux occurs when the lower esophageal sphincter (LES) weakens or relaxes inappropriately, failing to prevent gastric contents from returning to the food pipe. Treatment typically begins with lifestyle modifications such as dietary changes (avoiding trigger foods), weight loss, and elevating the head of the bed. Pharmacological interventions include antacids for immediate relief, H2-receptor blockers to reduce acid production, and proton pump inhibitors (PPIs) as the most effective agents for sustained acid suppression and healing. For severe or refractory cases, surgical options like fundoplication may be considered to reinforce the lower esophageal sphincter. The hallmark symptom is heartburn, a burning sensation in the chest that often worsens after eating, at night, or when lying down. Other common symptoms include regurgitation of food or sour liquid, chest pain, dysphagia (difficulty swallowing), chronic cough, hoarseness, and feeling a lump in the throat (globus sensation). Less common symptoms can include nausea, bad breath, or dental erosion.
Heart Failure with Reduced Ejection Fraction
Heart Failure with Reduced Ejection Fraction (HFrEF) is a clinical syndrome characterized by the heart's inability to pump sufficient blood to meet the body's metabolic demands due to impaired systolic function of the left ventricle, typically defined by a left ventricular ejection fraction (LVEF) of 40% or less. Treatment for HFrEF focuses on guideline-directed medical therapy (GDMT) including angiotensin receptor-neprilysin inhibitors (ARNI), beta-blockers, mineralocorticoid receptor antagonists (MRA), and sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce mortality and morbidity. Diuretics are used for symptom relief from congestion, and device therapies like implantable cardioverter-defibrillators (ICD) or cardiac resynchronization therapy (CRT) may be indicated for selected patients. Lifestyle modifications, such as dietary sodium restriction and fluid management, are also crucial. Patients commonly present with progressive exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, and fatigue due to reduced forward flow. Physical signs may include peripheral edema, jugular venous distension, pulmonary rales (crackles), an S3 gallop, and hepatomegaly, indicating fluid congestion.
Insulin Deficiency
Insulin deficiency is a metabolic condition characterized by inadequate production or complete absence of insulin from the pancreatic beta cells, resulting in impaired glucose utilization and elevated blood glucose levels. This typically leads to a diagnosis of Type 1 Diabetes Mellitus or represents a late stage of other pancreatic diseases. The mainstay of treatment is lifelong exogenous insulin replacement, administered through multiple daily injections or an insulin pump, to mimic physiological insulin secretion. Management also involves diligent blood glucose monitoring, carbohydrate counting, dietary adjustments, and regular physical activity to optimize glycemic control and prevent complications. Key symptoms include polyuria (frequent urination), polydipsia (excessive thirst), polyphagia (increased hunger), and unexplained weight loss. Patients often experience fatigue, blurred vision, recurrent infections, and in acute severe cases, symptoms of diabetic ketoacidosis such as nausea, vomiting, abdominal pain, and rapid, deep breathing (Kussmaul respirations).
Iron Deficiency Anemia: Evaluation and Management
The evaluation of anemia begins with a complete blood count (CBC). A microcytic, hypochromic anemia (low MCV, low MCH) is highly suggestive of iron deficiency anemia (IDA), especially in women of childbearing age with a history of heavy menses. The diagnosis is confirmed by iron studies showing low serum iron, low ferritin, and high total iron-binding capacity (TIBC). The first-line treatment is oral iron supplementation (e.g., ferrous sulfate). Re-evaluation of hemoglobin levels should occur after 2-4 weeks to ensure an adequate response.
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a common, chronic functional gastrointestinal disorder characterized by recurrent abdominal pain associated with altered bowel habits, without any identifiable structural or biochemical abnormalities. Management involves a combination of dietary modifications, lifestyle changes, and pharmacotherapy tailored to the predominant symptoms. Dietary approaches like the low-FODMAP diet, stress management techniques, and regular exercise are often recommended. Medications include antispasmodics for pain, laxatives for constipation, anti-diarrheals, and sometimes low-dose tricyclic antidepressants or selective serotonin reuptake inhibitors to modulate pain and gut function. Psychological therapies such as cognitive behavioral therapy (CBT) are also effective. Key symptoms include recurrent abdominal pain, often cramping, which is related to defecation or a change in stool frequency or form. Patients experience altered bowel habits, presenting as predominant diarrhea (IBS-D), constipation (IBS-C), or a mixed pattern (IBS-M). Other common symptoms include bloating, gas, abdominal distension, and a sense of incomplete evacuation.
Lymphedema
Lymphedema is a chronic, progressive condition characterized by localized fluid retention and tissue swelling, primarily in the limbs, due to impaired lymphatic system drainage. It results from a malfunctioning or damaged lymphatic system that is unable to effectively return protein-rich interstitial fluid to the systemic circulation. Treatment primarily involves Complex Decongestive Therapy (CDT), which includes manual lymphatic drainage, compression therapy (bandaging and garments), meticulous skin care to prevent infections, and therapeutic exercises. Surgical interventions, such as lymphovenous bypass, vascularized lymph node transfer, or debulking procedures (e.g., liposuction), may be considered for select patients who do not respond adequately to conservative management. Key symptoms include persistent swelling of an extremity or body part, often described as a feeling of heaviness or fullness, aching, and discomfort. Signs can include skin changes such as thickening, hardening (fibrosis), hyperkeratosis, papillomatosis, and impaired range of motion. Recurrent infections, particularly cellulitis, are also common.
Major Depressive Disorder: Diagnosis and Treatment
Major Depressive Disorder (MDD) is diagnosed when a patient experiences at least 5 of 9 typical symptoms (including depressed mood or anhedonia) for at least 2 weeks, causing significant impairment. First-line pharmacological treatment for MDD typically involves Selective Serotonin Reuptake Inhibitors (SSRIs) such as sertraline, fluoxetine, or citalopram. Cognitive Behavioral Therapy (CBT) is also a highly effective first-line psychotherapy. A combination of pharmacotherapy and psychotherapy often yields the best outcomes.
Maternal Physiological Adaptations in Pregnancy
During a normal singleton pregnancy, the maternal circulatory system undergoes remarkable physiological adaptations to support the developing fetus, meet increased metabolic demands, and prepare for the demands of labor and delivery. These changes are initiated early in gestation and progress throughout pregnancy, typically peaking by 32-34 weeks. One of the most critical and prominent adaptations is a significant expansion of the total maternal blood volume. Plasma volume increases disproportionately, typically by 40-50% above non-pregnant levels. Red blood cell mass also increases, but to a lesser extent, usually by 20-30% (more with adequate iron supplementation). The combined effect results in an overall increase in total blood volume by approximately 40-45% by term.
Metastatic breast cancer
Metastatic breast cancer (MBC), also known as stage IV breast cancer, occurs when breast cancer cells have spread beyond the breast and regional lymph nodes to distant organs in the body. It is an incurable but treatable disease focused on controlling progression and improving quality of life. Treatment for metastatic breast cancer is primarily palliative, aiming to control disease progression, alleviate symptoms, and maintain or improve quality of life. It involves systemic therapies tailored to the tumor's biological characteristics (e.g., hormone receptor status, HER2 status) and prior treatments, including chemotherapy, hormone therapy, targeted therapy (e.g., CDK4/6 inhibitors, anti-HER2 drugs), and immunotherapy. Localized treatments like radiation therapy or surgery may be used to manage specific symptomatic lesions or complications. Symptoms vary significantly depending on the site of metastasis. Common manifestations include bone pain (bone metastases), shortness of breath or persistent cough (lung metastases), jaundice or abdominal discomfort (liver metastases), and headaches, seizures, or neurological deficits (brain metastases). Systemic symptoms such as severe fatigue, unexplained weight loss, and general malaise are also frequently observed.
Mitral Regurgitation
Mitral regurgitation (MR) is a heart valve disorder in which the mitral valve, located between the left atrium and left ventricle, fails to close properly during systole, causing blood to leak backward into the left atrium. This backward flow reduces the amount of blood pumped forward to the body and can lead to increased pressure in the left atrium and lungs. Management strategies range from medical therapy to surgical or transcatheter intervention, depending on the severity and etiology. Medical treatments, including diuretics, vasodilators, and beta-blockers, are used to manage symptoms and reduce cardiac workload. Surgical repair or replacement of the mitral valve is often recommended for severe symptomatic MR or asymptomatic MR with evidence of progressive left ventricular dysfunction or dilation. Percutaneous transcatheter mitral valve repair is an option for select high-risk patients. Common symptoms include shortness of breath (dyspnea), fatigue, palpitations, and peripheral edema, particularly with exertion, due to reduced cardiac output and pulmonary congestion. A characteristic holosystolic murmur is typically heard best at the apex and radiates to the axilla. In severe or chronic cases, signs of left-sided heart failure such as crackles in the lungs, jugular venous distention, and an S3 gallop may be present.
Nephrolithiasis (Kidney Stones): Evaluation and Management
Nephrolithiasis typically presents with acute, severe, colicky flank pain that may radiate to the groin, often accompanied by hematuria, nausea, and vomiting. The gold standard imaging modality for diagnosing kidney stones is a non-contrast CT scan of the abdomen and pelvis. It offers high sensitivity and specificity for detecting stones, determining their size and location, and identifying associated complications like hydronephrosis. Initial management focuses on pain control (NSAIDs or opioids) and hydration. Stones smaller than 5mm often pass spontaneously.
Parkinson's Disease: Clinical Features and Diagnosis
Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons in the substantia nigra. The diagnosis is primarily clinical, based on the presence of cardinal motor features: resting tremor (often described as 'pill-rolling'), bradykinesia (slowness of movement), rigidity (cogwheel rigidity), and postural instability (which tends to occur later in the disease course). A positive response to dopaminergic therapy (like Levodopa) further supports the diagnosis.
Primary Hypothyroidism: Diagnosis and Management
Primary hypothyroidism is characterized by an underactive thyroid gland, resulting in decreased production of thyroid hormones. Common symptoms include fatigue, weight gain, cold intolerance, constipation, and dry skin. The diagnosis is established by finding an elevated Thyroid Stimulating Hormone (TSH) and a low free Thyroxine (Free T4). The standard treatment is daily replacement therapy with synthetic levothyroxine (T4). The goal of therapy is to normalize the serum TSH level, which should be rechecked 6-8 weeks after initiating or adjusting the dose.
Pulmonary Embolism
Pulmonary embolism (PE) is a life-threatening condition caused by a blockage in one of the pulmonary arteries in the lungs, most commonly due to a blood clot that has traveled from a deep vein in the legs or pelvis (deep vein thrombosis). This obstruction impedes blood flow to parts of the lung, leading to impaired gas exchange and potential cardiovascular collapse. Acute treatment typically involves prompt anticoagulation with agents such as unfractionated heparin, low molecular weight heparin, or direct oral anticoagulants (DOACs) to prevent clot propagation and new clot formation. In high-risk PE with hemodynamic instability, thrombolysis (fibrinolysis) may be administered to dissolve the clot. Surgical pulmonary embolectomy or catheter-directed interventions are considered for patients with massive PE who cannot receive or have failed thrombolysis. Symptoms are often non-specific and can include sudden onset of dyspnea, pleuritic chest pain (pain on breathing), and cough. Signs may include tachypnea (rapid breathing), tachycardia (rapid heart rate), hypoxemia, and in severe cases, syncope, hypotension, or signs of right heart failure. Hemoptysis (coughing up blood) may also occur.
Septic shock
Septic shock is a life-threatening condition characterized by circulatory, cellular, and metabolic abnormalities that are profound enough to substantially increase mortality, stemming from a dysregulated host response to infection. It is a subset of sepsis where patients require vasopressors to maintain an adequate mean arterial pressure and have elevated serum lactate despite adequate fluid resuscitation. Immediate management involves rapid administration of broad-spectrum antibiotics, aggressive intravenous fluid resuscitation (typically crystalloids), and vasopressors (e.g., norepinephrine) to restore and maintain adequate blood pressure and organ perfusion. Source control of infection (e.g., drainage of abscess, removal of infected device) is critical. Supportive care, including mechanical ventilation, renal replacement therapy, and glycemic control, is often required. Patients present with signs of severe infection and profound circulatory dysfunction, including persistent hypotension requiring vasopressors to maintain a mean arterial pressure of 65 mmHg or greater, despite adequate fluid resuscitation, and a serum lactate level > 2 mmol/L. Other manifestations of organ dysfunction may include altered mental status, oliguria, tachycardia, tachypnea, fever or hypothermia, and mottled skin.
Stable Angina Pectoris: Clinical Evaluation
Stable angina is characterized by episodic chest discomfort that is predictably provoked by exertion or emotional stress and relieved by rest or nitroglycerin. The initial evaluation involves a thorough history and physical examination, followed by a resting ECG. If the patient can exercise and has a normal resting ECG, an exercise stress test (treadmill ECG) is the preferred initial non-invasive functional test for diagnosing ischemic heart disease. Patients with abnormal resting ECGs or inability to exercise require imaging-based stress testing (e.g., stress echocardiography or nuclear perfusion imaging).
Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by widespread inflammation and tissue damage, as the immune system mistakenly attacks its own healthy tissues and organs. It can affect nearly any part of the body, including joints, skin, kidneys, brain, heart, and lungs. Treatment for SLE aims to control symptoms, reduce inflammation, prevent organ damage, and minimize flare-ups. This typically involves corticosteroids for acute flares, antimalarials (e.g., hydroxychloroquine) for long-term disease control, and immunosuppressants (e.g., methotrexate, azathioprine, mycophenolate mofetil) for moderate to severe disease. Biologic agents (e.g., belimumab, anifrolumab) are also used for targeted immunomodulation. SLE presents with a diverse range of symptoms due to multi-organ involvement. Common manifestations include joint pain and swelling (arthritis/arthralgia), a characteristic butterfly-shaped malar rash, photosensitivity, oral ulcers, and profound fatigue. More severe features can include lupus nephritis (kidney inflammation), neurological issues (seizures, psychosis), serositis (inflammation of lining of lungs or heart), and hematologic abnormalities (anemia, leukopenia, thrombocytopenia).
Urosepsis
Urosepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection originating from the urinary tract. It represents a severe systemic inflammatory response syndrome (SIRS) triggered by a urinary tract infection (UTI). Treatment involves immediate initiation of broad-spectrum intravenous antibiotics, empirically selected to cover common uropathogens, and subsequently narrowed based on culture sensitivities. Aggressive supportive care, including intravenous fluid resuscitation to correct hypotension, and vasopressors if needed, is crucial to maintain organ perfusion. Source control, such as removal of an obstructed catheter or drainage of a collection, is also a critical component of management. Patients commonly present with signs of systemic infection, including high fever, chills, tachycardia, and hypotension. They may also exhibit symptoms related to the urinary source, such as dysuria, flank pain, urgency, or suprapubic tenderness. Signs of organ dysfunction like altered mental status, oliguria, tachypnea, or mottled skin may also be present, indicating severe sepsis or septic shock.
Volvulus
Volvulus is a medical condition characterized by the twisting of a loop of intestine around itself and its mesentery, leading to bowel obstruction and potential compromise of blood supply (ischemia). It is a surgical emergency that can affect any part of the gastrointestinal tract, most commonly the sigmoid colon or cecum in adults, and the midgut in infants. Urgent surgical intervention is the definitive treatment for most cases of volvulus to untwist the bowel (detorsion) and assess for viability. If the bowel is found to be gangrenous or non-viable, resection of the affected segment with either primary anastomosis or ostomy formation (e.g., colostomy) is performed. In select cases of sigmoid volvulus, endoscopic detorsion may be attempted as a bridge to elective surgery or in stable, non-ischemic patients. Patients typically experience sudden onset of severe, colicky abdominal pain that may be constant, accompanied by abdominal distension and obstipation (inability to pass flatus or stool). Nausea and vomiting are common, and in infants, bilious vomiting is a key sign of midgut volvulus. As ischemia progresses, signs of peritonitis, such as guarding, rigidity, and rebound tenderness, may develop.